CVS gave its 2019 earnings forecast, which fell well short of expectations, disappointing investors and stoking fears about CVS' core business. » Read More
Bristol-Myers Squibb confirms Starboard's stake in the company and says the $74 billion deal to acquire cancer drugmaker Celgene is "on track" to close during the third quarter. » Read More
U.S. healthcare plan and pharmacy benefits manager Magellan Health will explore selling itself after coming under pressure to do so from activist hedge fund Starboard Value LP, people familiar with the matter said on Wednesday. » Read More
A company that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss, NBC News reports. » Read More
The FDA is advising against "young blood" infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
Medical device maker Medtronic on Tuesday beat Wall Street estimates for quarterly profit, driven by higher sales in its surgical products unit and restorative therapies group.
"I've never seen a sector have the political tailwinds, the economic tailwinds, and the wellness tailwinds that this sector potentially has," said legendary investor Danny Moses.
Despite competition from other drugmakers, Pfizer has been able to maintain a significant share in the erectile dysfunction market thanks in part to launching its own generic version of the blue, diamond-shaped pill.
The purchase gives J&J, one of the world's largest maker of health products, an entry into robotics and builds on the company's partnership with Alphabet's Verily.
CVS Health is unveiling its new health-focused concept store that's designed to help the drugstore become more like a health-care provider than a place to pick up prescriptions and greeting cards.